Bunkerhill Health
Bunkerhill is building the System of Action for Health Systems
Est 2018|Valuation $130M
Bunkerhill is building the System of Action for Health Systems
Published Oct 13, 2026
No detailed public "known issues" page for the platform was found during this research.
No public product roadmap with dates was found in available sources.
Without public SLOs or reliability reporting, it is not possible to validate latency, throughput at large health system volumes, or uptime and incident history.
The vendor publishes developer documentation for an Inference API (model inference objects, study file URLs, inputs/outputs), but API documentation alone does not guarantee turnkey EHR integration. Buyers should validate integration patterns, reference implementations, and support for closed-loop EHR actions during procurement.
Probable selection drivers based on published workflows and announcements:
No substantive public product review pages were found on major review sites during this research run. This limits the ability to triangulate independent user feedback via those platforms.
Implication: buyers should plan to rely on direct reference calls with named customers, paid analyst reports, or provider announcements when evaluating operational performance and support.
Searches did not surface substantial end-user discussions about Carebricks on public forums. This may reflect brand-name collisions, a user base that discusses vendors in private channels, or limited public exposure to date.
The only testimonial-style quotes readily available on public pages are vendor-published statements. Example:
Caveat: vendor-hosted quotes are selective and should be treated as promotional material rather than independent validation.
Possible reasons for non-adoption or churn, based on category dynamics and vendor visibility:
Stamford Health published an announcement describing use of an AI tool (provided by the vendor) to calculate CAC/Agatston scores and support early detection and follow-up. This provider announcement is an independent signal of deployment but is still promotional in nature and does not typically include hard operational metrics.
The vendor references multiple FDA clearances. FDA 510(k) summaries provide evidence that specific algorithms meet regulatory requirements for their intended use cases. FDA clearance covers the intended function and safety assertions in the submitted materials but does not guarantee local workflow ROI, provider adoption, or reductions in adverse events.
Most plausible ICP:
Decision makers:
End users:
Primary target customers appear to be mid-to-large US health systems and academic medical centers (enterprise buyers), particularly those seeking system-level automation of follow-up workflows and scalable opportunistic screening from imaging. The vendor positions the product as an enterprise clinical workflow automation and AI platform rather than a single-model radiology AI vendor.
Get a comprehensive analysis of Bunkerhill Health including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Scenarios where alternatives may be more appropriate:
The vendor publishes a case study describing use of its iCAC algorithm to automate coronary calcium scoring and support cardiovascular risk stratification.
Critical evaluation:
Bunkerhill Health describes Carebricks as a platform intended to support health systems in building automated clinical and operational workflows. Carebricks is designed to:
The vendor uses the framework "Knowledge → Reasoning → Action → Creation" to describe its workflow capabilities. Published workflow examples include:
Key publicly visible product components: